Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events Academic Article uri icon

Overview

MeSH Major

  • Anticholesteremic Agents
  • C-Reactive Protein
  • Coronary Disease
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lovastatin

abstract

  • Statin therapy may be effective in the primary prevention of coronary events among subjects with relatively low lipid levels but with elevated levels of C-reactive protein.

publication date

  • June 28, 2001

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1056/NEJM200106283442601

PubMed ID

  • 11430324

Additional Document Info

start page

  • 1959

end page

  • 65

volume

  • 344

number

  • 26